Jane Hankins - Publications

Affiliations: 
University of Memphis, Memphis, TN, United States 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang W, Brown C, McNaull M, Rogers ZR, Barton M, Dua M, Hankins JS, Gossett JM, Richardson J, Porter JS, Kang G, Estepp J. Intensive hydroxyurea dosing in very young children with sickle cell anemia. Blood Advances. PMID 37695741 DOI: 10.1182/bloodadvances.2022009613  0.689
2023 Pizzo A, Porter JS, Carroll Y, Burcheri A, Smeltzer MP, Beestrum M, Nwosu C, Badawy SM, Hankins JS, Klesges LM, Alberts NM. Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators. British Journal of Haematology. PMID 37691131 DOI: 10.1111/bjh.19099  0.716
2023 Howell KE, Pugh N, Longoria J, Shah N, Kutlar A, Gordeuk VR, King AA, Glassberg J, Kayle M, Melvin C, Treadwell M, Hankins JS, Porter JS. Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease. Hemasphere. 7: e930. PMID 37456969 DOI: 10.1097/HS9.0000000000000930  0.769
2023 Bhatt N, Calhoun C, Longoria J, Nwosu C, Howell KE, Varughese T, Kang G, Jacola LM, Hankins JS, King A. Health literacy correlates with abbreviated full-scale IQ in adolescent and young adults with sickle cell disease. Pediatric Blood & Cancer. e30281. PMID 36861391 DOI: 10.1002/pbc.30281  0.777
2022 Howell KE, Heitzer AM, Longoria JN, Potter B, Wang WC, Anderson S, Kang G, Hankins JS, Porter JS. Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease. Expert Review of Hematology. 1-10. PMID 36356169 DOI: 10.1080/17474086.2022.2144216  0.767
2022 Heitzer AM, Schreiber JE, Yuan X, Wang F, Pan H, Graff JC, Murphy L, Rupff R, Russell K, Wang W, Estepp JH, Hankins JS, Porter JS, Jacola LM. Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls. British Journal of Haematology. PMID 36264030 DOI: 10.1111/bjh.18507  0.649
2022 Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins JS. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. Current Research in Translational Medicine. 70: 103335. PMID 35303690 DOI: 10.1016/j.retram.2022.103335  0.632
2022 Zahr RS, Ding J, Kang G, Wang WC, Hankins JS, Ataga KI, Lebensburger JD, Porter JS. Enuresis and Hyperfiltration in Children With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. PMID 35180759 DOI: 10.1097/MPH.0000000000002426  0.32
2022 Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. British Journal of Haematology. PMID 35118643 DOI: 10.1111/bjh.18041  0.329
2021 Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatric Blood & Cancer. e29531. PMID 34971013 DOI: 10.1002/pbc.29531  0.69
2021 Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, Tanabe P, Badawy SM, DiMartino L, Gibson R, Kanter J, Klesges LM, Hankins JS. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. Bmj Open. 11: e050880. PMID 34789492 DOI: 10.1136/bmjopen-2021-050880  0.765
2021 Mathias JG, Nolan VG, Klesges LM, Badawy SM, Cooper WO, Hankins JS, Smeltzer MP. Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance. Jama Network Open. 4: e2128971. PMID 34643722 DOI: 10.1001/jamanetworkopen.2021.28971  0.79
2021 Champlin G, Hwang SN, Heitzer A, Ding J, Jacola L, Estepp JH, Wang W, Ataga KI, Owens CL, Newman J, King AA, Davis R, Kang G, Hankins JS. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia. Experimental Biology and Medicine (Maywood, N.J.). 15353702211035778. PMID 34407676 DOI: 10.1177/15353702211035778  0.671
2021 Howell KE, Saulsberry-Abate AC, Mathias JG, Porter JS, Hodges JR, Ataga KI, Anderson S, Nolan V, Hankins JS. Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease. Pediatric Blood & Cancer. e29209. PMID 34286896 DOI: 10.1002/pbc.29209  0.763
2021 Rampersaud E, Kang G, Palmer LE, Rashkin SR, Wang S, Bi W, Alberts NM, Anghelescu D, Barton M, Birch K, Boulos N, Brandow AM, Brooke RJ, Chang TC, Chen W, ... ... Hankins JS, et al. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease. Blood Advances. 5: 2839-2851. PMID 34283174 DOI: 10.1182/bloodadvances.2021004634  0.663
2021 Rashkin SR, Rampersaud E, Kang G, Ataga KI, Hankins JS, Wang W, Estepp JH, Weiss MJ, Lebensburger J, Zahr RS. Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results. British Journal of Haematology. PMID 34137022 DOI: 10.1111/bjh.17647  0.68
2021 Estepp JH, Cong Z, Agodoa I, Kang G, Ding J, McCarville MB, Hankins JS, Wang WC. What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study. British Journal of Haematology. 194: 463-468. PMID 34131902 DOI: 10.1111/bjh.17620  0.657
2021 Whipple NS, Joshi VM, Naik RJ, Mentnech T, McFarland MM, Nolan VG, Hankins JS. Sickle cell disease and ventricular myocardial strain: A systematic review. Pediatric Blood & Cancer. e28973. PMID 33742492 DOI: 10.1002/pbc.28973  0.553
2020 Mathias JG, Nolan VG, Meadows-Taylor M, Robinson LA, Howell KE, Gurney JG, Hankins JS, Wang WC, Estepp JH, Smeltzer MP. A meta-analysis of toxicities related to hydroxycarbamide dosing strategies. Ejhaem. 1: 235-238. PMID 35847723 DOI: 10.1002/jha2.7  0.697
2020 Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Chen Y, Wilson CL, Estepp J, Rai P, Hankins JS, Burridge PW, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, et al. Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry. Cancer Research. PMID 33288658 DOI: 10.1158/0008-5472.CAN-20-2675  0.638
2020 Kanter J, Gibson R, Lawrence RH, Smeltzer MP, Pugh NL, Glassberg J, Masese RV, King AA, Calhoun C, Hankins JS, Treadwell M. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care. Jama Network Open. 3: e206016. PMID 32469413 DOI: 10.1001/jamanetworkopen.2020.6016  0.731
2020 Alberts NM, Badawy SM, Hodges J, Estepp JH, Nwosu C, Khan H, Smeltzer MP, Homayouni R, Norell S, Klesges L, Porter JS, Hankins JS. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach. Jmir Mhealth and Uhealth. 8: e14884. PMID 32383683 DOI: 10.2196/14884  0.787
2020 Lebensburger JD, Gossett J, Zahr R, Wang WC, Ataga KI, Estepp JH, Kang G, Hankins JS. High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia. Haematologica. PMID 32107332 DOI: 10.3324/haematol.2019.242156  0.642
2019 El-Gohary Y, Fleming A, Zhang H, Estepp JH, Hankins JS, Wang W, Davidoff AM, Murphy AJ. Acute Chest Syndrome After Splenectomy in Children With Sickle Cell Disease. The Journal of Surgical Research. 242: 336-341. PMID 31129243 DOI: 10.1016/j.jss.2019.04.077  0.675
2019 Adesina OO, Gurney JG, Kang G, Villavicencio M, Hodges JR, Chemaitilly W, Kaste SC, Zemel BS, Hankins JS. Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results. Blood Advances. 3: 1476-1488. PMID 31072833 DOI: 10.1182/Bloodadvances.2018026047  0.526
2019 Yates AM, Joshi VM, Aygun B, Moen J, Smeltzer MP, Govindaswamy D, Dowdy J, Cotton A, Kang G, Ware RE, Hankins JS. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates. Pediatric Blood & Cancer. e27717. PMID 30907497 DOI: 10.1002/pbc.27717  0.725
2019 Zahr RS, Rampersaud E, Kang G, Weiss MJ, Wu G, Davis RL, Hankins JS, Estepp JH, Lebensburger J. Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life. Haematologica. PMID 30890594 DOI: 10.3324/Haematol.2018.212779  0.661
2018 Zahr RS, Hankins JS, Kang G, Li C, Wang WC, Lebensburger J, Estepp JH. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia. American Journal of Hematology. PMID 30359463 DOI: 10.1002/ajh.25329  0.689
2018 Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, et al. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. Pediatric Blood & Cancer. e27228. PMID 29797644 DOI: 10.1002/Pbc.27228  0.79
2017 Nolan VG, Anderson SM, Smeltzer MP, Porter JS, Carroll YM, Brooks IM, Elmagboul N, Gurney JG, Hankins JS. Pediatric to adult care Co-location transitional model for youth with sickle cell disease. American Journal of Hematology. PMID 29067725 DOI: 10.1002/Ajh.24953  0.795
2017 Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, Aygun B, Ware RE, Nottage K, Hankins JS. A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy. American Journal of Hematology. PMID 28913922 DOI: 10.1002/ajh.24906  0.805
2017 Cancio MI, Aygun B, Chui DHK, Rothman JA, Scott JP, Estepp JH, Hankins JS. The clinical severity of hemoglobin S/Black ((A) γδβ)(0) -thalassemia. Pediatric Blood & Cancer. PMID 28453928 DOI: 10.1002/pbc.26596  0.668
2016 Loeffler RB, McCarville MB, Wagstaff AW, Smeltzer MP, Krafft AJ, Song R, Hankins JS, Hillenbrand CM. Can multi-slice or navigator-gated R2* MRI replace single-slice breath-hold acquisition for hepatic iron quantification? Pediatric Radiology. PMID 27752732 DOI: 10.1007/s00247-016-3700-1  0.66
2016 Nottage KA, Ware RE, Aygun B, Smeltzer M, Kang G, Moen J, Wang WC, Hankins JS, Helton KJ. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia. British Journal of Haematology. PMID 27604981 DOI: 10.1111/bjh.14235  0.712
2016 Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J. Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease. Pediatrics. PMID 27335380 DOI: 10.1542/Peds.2015-3479  0.661
2016 Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Clinical Trials (London, England). PMID 27000103 DOI: 10.1177/1740774516636573  0.69
2016 Smeltzer MP, Nolan VG, Yu X, Nottage KA, Davis BA, Yang Y, Wang WC, Gurney JG, Hankins JS. Birth Prevalence of Sickle Cell Trait and Sickle Cell Disease in Shelby County, TN. Pediatric Blood & Cancer. PMID 26871988 DOI: 10.1002/Pbc.25936  0.776
2015 Hankins JS, McCarville MB, Rankine-Mullings A, Reid ME, Lobo CL, Moura PG, Ali S, Soares D, Aldred K, Jay DW, Aygun B, Bennett J, Kang G, Goldsmith JC, Smeltzer MP, et al. Prevention of conversion to abnormal tcd with hydroxyurea in sickle cell anemia: A phase III international randomized clinical trial. American Journal of Hematology. PMID 26414435 DOI: 10.1002/ajh.24198  0.715
2015 Smeltzer MP, Nolan VG, Yu X, Nottage KA, Wang WC, Hankins JS, Gurney JG. Distance from an Urban Sickle Cell Center and its Effects on Routine Healthcare Management and Rates of Hospitalization. Hemoglobin. 1-6. PMID 26372097 DOI: 10.3109/03630269.2015.1084315  0.781
2015 Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG. Prevalence of vitamin D deficiency in sickle cell disease: a systematic review. Plos One. 10: e0119908. PMID 25734582 DOI: 10.1371/Journal.Pone.0119908  0.669
2015 Helton KJ, Glass JO, Reddick WE, Paydar A, Zandieh AR, Dave R, Smeltzer MP, Wu S, Hankins J, Aygun B, Ogg RJ. Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia. Journal of Magnetic Resonance Imaging : Jmri. 41: 439-46. PMID 24920128 DOI: 10.1002/Jmri.24559  0.705
2014 Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Medicine. 93: e215. PMID 25526439 DOI: 10.1097/MD.0000000000000215  0.707
2014 Estepp JH, Winter B, Johnson M, Smeltzer MP, Howard SC, Hankins JS. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatric Blood & Cancer. 61: 2031-6. PMID 25132074 DOI: 10.1002/pbc.25177  0.792
2014 Porter JS, Matthews CS, Carroll YM, Anderson SM, Smeltzer MP, Hankins JS. Genetic education and sickle cell disease: feasibility and efficacy of a program tailored to adolescents. Journal of Pediatric Hematology/Oncology. 36: 572-7. PMID 25089602 DOI: 10.1097/Mph.0000000000000226  0.691
2014 Hankins JS, Verevkina NI, Smeltzer MP, Wu S, Aygun B, Clarke DF. Assessment of sleep-related disorders in children with sickle cell disease. Hemoglobin. 38: 244-51. PMID 24941261 DOI: 10.3109/03630269.2014.919941  0.681
2014 Nottage KA, Ware RE, Winter B, Smeltzer M, Wang WC, Hankins JS, Dertinger SD, Shulkin B, Aygun B. Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. European Journal of Haematology. 93: 377-83. PMID 24796940 DOI: 10.1111/Ejh.12361  0.713
2013 Nottage KA, Hankins JS, Smeltzer M, Mzayek F, Wang WC, Aygun B, Gurney JG. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. Plos One. 8: e72077. PMID 23967276 DOI: 10.1371/journal.pone.0072077  0.745
2013 Estepp JH, Smeltzer MP, Wang WC, Hoehn ME, Hankins JS, Aygun B. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. British Journal of Haematology. 161: 402-5. PMID 23384083 DOI: 10.1111/bjh.12238  0.79
2013 Finch P, Stocks RM, Smeltzer MP, Kimble A, Schoumacher R, Hankins JS. Effects of adenotonsillectomy on polysomnographic parameters in children with sickle cell disease. Pediatric Blood & Cancer. 60: E26-8. PMID 23382091 DOI: 10.1002/Pbc.24479  0.699
2013 Cook CM, Smeltzer MP, Mortier NA, Kirk SE, Despotovic JM, Ware RE, Hankins JS. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease. Hemoglobin. 37: 16-25. PMID 23297836 DOI: 10.3109/03630269.2012.753547  0.678
2013 Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia American Journal of Hematology. 88: 116-119. PMID 23255310 DOI: 10.1002/ajh.23365  0.713
2013 Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies Leukemia and Lymphoma. 54: 1719-1723. PMID 23163568 DOI: 10.3109/10428194.2012.750724  0.748
2012 Hankins JS, Osarogiagbon R, Adams-Graves P, McHugh L, Steele V, Smeltzer MP, Anderson SM. A transition pilot program for adolescents with sickle cell disease. Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners. 26: e45-9. PMID 22819193 DOI: 10.1016/j.pedhc.2012.06.004  0.718
2012 Cejda KR, Smeltzer MP, Hansbury EN, McCarville ME, Helton KJ, Hankins JS. The impact of preparation and support procedures for children with sickle cell disease undergoing MRI Pediatric Radiology. 42: 1223-1228. PMID 22710740 DOI: 10.1007/s00247-012-2422-2  0.716
2011 Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia Pediatric Nephrology. 26: 1285-1290. PMID 21559933 DOI: 10.1007/s00467-011-1857-2  0.715
2011 Aygun B, Parker J, Freeman MB, Stephens AL, Smeltzer MP, Wu S, Hankins JS, Wang WC. Neurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease. Pediatric Blood & Cancer. 56: 620-4. PMID 21298749 DOI: 10.1002/Pbc.22833  0.734
2010 Hankins JS, McCarville MB, Hillenbrand CM, Loeffler RB, Ware RE, Song R, Smeltzer MP, Joshi V. Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition Pediatric Blood and Cancer. 55: 495-500. PMID 20658621 DOI: 10.1002/pbc.22587  0.688
2010 Hankins JS, Smeltzer MP, McCarville MB, Aygun B, Hillenbrand CM, Ware RE, Onciu M. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload European Journal of Haematology. 85: 51-57. PMID 20374273 DOI: 10.1111/j.1600-0609.2010.01449.x  0.671
2010 McCarville MB, Hillenbrand CM, Loeffler RB, Smeltzer MP, Song R, Li CS, Hankins JS. Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload Pediatric Radiology. 40: 1360-1367. PMID 20333511 DOI: 10.1007/S00247-010-1596-8  0.669
2009 Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 113: 4853-5. PMID 19264677 DOI: 10.1182/blood-2008-12-191643  0.671
2009 Helton KJ, Paydar A, Glass J, Weirich EM, Hankins J, Li CS, Smeltzer MP, Wang WC, Ware RE, Ogg RJ. Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia. Pediatric Blood & Cancer. 52: 85-91. PMID 18937311 DOI: 10.1002/Pbc.21745  0.699
2008 Hankins JS, Fortner GL, McCarville MB, Smeltzer MP, Wang WC, Li CS, Ware RE. The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia. British Journal of Haematology. 142: 94-9. PMID 18477038 DOI: 10.1111/J.1365-2141.2008.07167.X  0.716
Show low-probability matches.